Diego Celli
Houston, TXNPI 1285194886
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Abbott at 56.4% of the total. 2025 is the largest year on record at $10,261, 9.5 times the $1,084 reported in 2022.
Across 262 payments — averaging $74.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$11K
- Boston Scientific$3K
- Edwards Lifesciences$2K
- Medtronic$557
- Cardiva Medical, Inc.$410
- Abiomed$248
- plus $2K from 20 others
What the payments were for
- Travel & lodging$7,31738%
- Food & beverage$11,64960%
- Education$4782%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 114 | $10,963 |
| Boston Scientific | 31 | $3,242 |
| Edwards Lifesciences | 33 | $2,018 |
| Medtronic | 6 | $557 |
| Cardiva Medical, Inc. | 11 | $410 |
| Abiomed | 7 | $248 |
| Pfizer | 12 | $236 |
| Actelion Pharmaceuticals US, Inc. | 7 | $220 |
| Shockwave Medical, Inc | 4 | $190 |
| Teleflex LLC | 2 | $183 |
| Penumbra, Inc. | 1 | $175 |
| Cardiovascular Systems Inc. | 2 | $156 |
| Bridgebio Pharma, Inc. | 3 | $121 |
| Amgen | 7 | $120 |
| Cvrx, Inc. | 1 | $87 |
| AstraZeneca | 4 | $86 |
| Inari Medical, Inc. | 1 | $85 |
| Novartis | 3 | $74 |
| Sanofi-aventis U.S. LLC | 3 | $69 |
| Johnson & Johnson | 3 | $54 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $45 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $33 |
| Lexicon Pharmaceuticals, Inc. | 1 | $27 |
| Heartflow, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$2,714
- PERCLOSE PROGLIDE$1,593
- SAPIEN 3 Ultra RESILIA$695
- DRAGONFLY OPSTAR$670
- ESPRIT$665
- SUPERA$592
- CARDIOMEMS$516
- Perclose ProStyle$502
- Diamondback Coronary$286
- JETSTREAM SC$177
- VenaSeal$175
- Indigo System$175
- Sentinel$173
- ENSITE PRECISION$172
- TURNPIKE$168
- ONYX FRONTIER$161
- Diamondback Peripheral$154
- GENERAL - THERAPIES$154
- COREVALVE EVOLUT R$149
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$144
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.